Bacterial traits that contribute to disease are termed 'virulence factors' and there is 16 much interest in therapeutic approaches that disrupt such traits. However, ecological 17 30 Understanding which bacterial characteristics contribute most to disease is a major 31 area of research in microbiology and infection biology (1-3). Bacterial characteristics 32 that reduce host health and/or survival are considered 'virulence factors'. Such 33 factors include structural features like flagella and pili that facilitate attachment to 34 host cells (4, 5), as well as secreted products like toxins and enzymes that degrade 35 host tissue (6, 7), or siderophores that scavenge iron from the host (8). Research on 36 virulence factors has not only increased our fundamental understanding of the 37 mechanisms underlying virulence, but has also identified potential novel targets for 38 antibacterial therapy. There is indeed much current interest in developing 'anti-39 virulence' drugs to disrupt virulence factor productionthe idea being that by simply 40 disarming pathogens rather than killing them outright, we could ostensibly elicit 41 weaker selection for drug resistance (9-11).
theory predicts disease severity to be multifactorial and context dependent, which 18 might complicate our efforts to identify the most generally important virulence factors. 19 Here, we use meta-analysis to quantify disease outcomes associated with one well-20 studied virulence factorpyoverdine, an iron-scavenging compound secreted by the 21 opportunistic pathogen Pseudomonas aeruginosa. Consistent with ecological theory, 22 we found that the effect of pyoverdine, albeit frequently contributing to disease, 23 varied considerably across infection models. In many cases its effect was relatively 24 minor, suggesting that pyoverdine is rarely essential for infections. Our work 25 demonstrates the utility of meta-analysis as a tool to quantify variation and overall 26 effects of purported virulence factors across different infection models. This 27 standardised approach will help us to evaluate promising targets for anti-virulence 28 approaches. 29 
INTRODUCTION
in a specific host context will similarly enhance virulence in another bacterial strain, Relationship between effect sizes and moderator variables. We combined data 112 from the set of experiments described above in a meta-analysis to determine the 113 extent to which pyoverdine's effect on virulence varied across four moderator 114 variables: (i) host taxa, (ii) tissue types, (iii) pathogen wildtype background, and (iv) 115 pyoverdine-mutation type. To obtain a comparable measure of virulence across 116 experiments, we extracted in each instance the number of cases where a given 117 infection type did or did not have a virulent outcome (i.e. dead vs. alive, or with vs. 118 without symptoms) for both the mutant (m) and the wildtype (w) strain for each 119 experiment (see materials and methods for details). We then took as our effect size 120 the log-odds-ratio, i.e. ln ((mvirulent / mnon-virulent) / (wvirulent / wnon-virulent)) (see Table S2 121 in the supplemental material), a commonly-used measure especially suitable for 122 binary response variables like survival (48) . 123 Consistent with the theoretical prediction that host-pathogen interactions and host 124 ecology are important modulators of virulence, we found considerable variation in 125 Finally, we observed that the nature of the pyoverdine-deficiency mutation matters 139 ( Fig. 1D ). Infections with strains carrying well-defined mutations known to exclusively 140 (or at least primarily) affect pyoverdine production showed a relatively consistent 141 reduction in virulence. Conversely, where mutants were poorly-defined, or carried 142 mutations likely to affect other traits beyond pyoverdine, here the virulence pattern 143 was much more variable, with both reduced and increased virulence relative to 144 wildtype infections (Fig. 1D ). We posit that at least some of the differences in 145 observed virulence between these mutants and their wildtype counterparts was likely 146 due to pleiotropic differences in phenotypes unrelated to pyoverdine. 147 148 Assessing the relative importance of moderator variables. Fig. 1 highlights 149 that we are dealing with an extremely heterogeneous dataset (a random meta-150 analyses of the full dataset without moderators yielded heterogeneity measures I 2 151 = 98.1% and H = 7.28). Much of the variation we observe is probably due to other 152 factors beyond those explored in Fig 1. The issue is that (a) we do not know what 153 all these additional factors might be, and (b) the probably patchy distribution of experiments across the levels and ranges of these other factors would leave us 155 with limited power to test for their effects. Accordingly, we decided to focus our 156 attention on quantifying the impact of the four previously described moderators by 157 using a more homogenous core dataset (n = 50), where rare and poorly 158 characterized subgroups were removed. Specifically, we excluded experiments 159 involving plants and / or undefined wildtype strains (n = 6), experiments reporting 160 tissue damage as a measure of virulence (n = 12) , and experiments where the hosts 161 were likely not colonized by bacteria but died from exposure to bacterial toxins (n = 162 8). This leaves us with a core dataset comprising only those experiments where 163 animal host models were infected with strains from well-defined PA14 or PA01 164 wildtype background, and survival vs. death was used as a virulence endpoint. 165 166 Using this restricted dataset, we performed a series of meta-regression models to 167 test for significant differences between subgroups of our moderator factors, and we 168 also estimated the share of total variance in effect sizes that is explained by each 169 moderator variable (Fig. 2) . These models revealed that infection type is the 170 variable that explains the largest share of total variance (25.6%). For instance, in 171 systemic infection models the pyoverdine-defective mutants showed strongly 172 reduced virulence compared to the wild-type, whereas this difference was less 173 pronounced in gut infections. Host taxon explained only 7.9% of the total variance 174 in effect sizes, and there was no apparent difference in the mean effect size 175 among invertebrate vs. mammalian host models. Finally, the wildtype strain 176 background and the likelihood of pleiotropy in the mutant strain both explained less 177 than 1% of the overall effect size variation, and accordingly, there were no 178 apparent differences between subgroups (Fig. 2 plotted the effect size of each experiment against its (inverted) standard error (Fig. 191 3). If there is no publication bias, we would expect to see an inverted funnel, with 192 effect sizes more or less evenly distributed around the mean effect size, irrespective 193 of the uncertainty associated with each estimate (i.e. position on the y-axis). Instead, 194 we observed a bias in our dataset, with many lower-certainty experiments that show 195 strongly negative effect sizes (i.e. supporting the hypothesis that pyoverdine is 196 important for virulence; Fig. 3 ) but a concomitant paucity of lower-certainty 197 experiments that show weakly negative, zero or positive effect sizes (i.e. not 198 supporting the hypothesis).
DISCUSSION
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What we can conclude from this meta-analysis. Our meta-analysis reveals that 201 pyoverdine-deficient strains of the opportunistic pathogen P. aeruginosa typically 202 showed reduced virulence across a wide range of host species and bacterial 203 genotypes. This confirms that iron limitation is a unifying characteristic of the host 204 environment, making siderophores an important factor for pathogen establishment 205 and growth within the host (50, 51) . Conversely, we also saw that the extent to which 206 pyoverdine deficiency reduced virulence varied considerably, and was quite modest 207 in many instances. Pyoverdine-deficient mutant strains were typically more benign, 208 owing to a reduced capacity for in vivo growth and/or a reduced capacity for inflicting 209 damage on their host. Nonetheless, these mutants were typically still able to 210 establish a successful infection, and, in many cases, could still kill their host (21, 22, 211 25, 40) . These results support ecological theory predicting that the effect of a certain 212 phenotype (i.e. producing pyoverdine in our case) should vary in response to the 213 environment (i.e. the host and infection context). Our findings have consequences for 214 any therapeutic approaches targeting this particular virulence factor as they reveal a 215 possible trade-off: such treatments could have wide applicability, but their (clinical) 216 impact would likely vary across infection contexts, and be limited to attenuating rather 217 than curing the infection. This would mean that for P. aeruginosa infections, at least, 218 therapies targeting siderophore production could be helpful but should probably still 219 be accompanied by other therapeutic measures (52).
221
Our work demonstrates how meta-analyses can be used to quantitatively synthesize 222 data from different experiments carried out at different times by different researchers 223 using different designs. Such an analytical approach goes beyond a classical review, 224 where patterns are typically summarized in a qualitative manner. For instance, a 225 recent study proposed that three different virulence factors (pyocyanin, protease, 226 swarming) of P. aeruginosa are host-specific in their effects (12). Here we use a 227 meta-analytic approach to quantitatively derive estimates of the overall virulence 228 potential of a given bacterial trait and investigate variables that affect infection 229 outcomes. We assert that such quantitative comparisons are essential to identify 230 those virulence factors that hold greatest promise as targets for effective broad-231 spectrum anti-virulence therapies. Figure 1 , the effect size it 240 reports is associated with a high uncertainty due to a comparatively low sample size. 241 Moreover, the observed effect cannot unambiguously be attributed to pyoverdine 242 because an undefined UV-mutagenized mutant was used. We highlight this example 243 not to criticise it, but rather because it serves to demonstrate why drawing inferences 244 from (appropriately weighted) aggregations of all available evidence is preferable to 245 focusing solely on the results of a single study. What we could conclude with additional data. Our meta-analytic approach not 248 only provides information on the overall importance of pyoverdine for P. aeruginosa virulence, but it also allows us to identify specific gaps in our knowledge and potential 250 biases in the published literature. First, most experiments in our dataset employed 251 acute infection models, even though P. aeruginosa is well known for its persistent, 252 hard-to-treat chronic infections. This raises the question to what extent insights on 253 the roles of virulence factors important in acute infections can be transferred to 254 chronic infections. In the case of pyoverdine, we know that in chronically-infected 255 cystic fibrosis airways, pyoverdine production is often selected against (54-56). 256 Although the selective pressure driving this evolutionary loss is still under debate 257 (current explanations include pyoverdine disuse, competitive strain interactions 258 and/or a switch to alternative iron-uptake systems (56-58)), this example illustrates 259 that the role of pyoverdine might differ in acute versus chronic infections.
261
Second, our comparative work shows that experiments were predominantly carried 262 out with the well-characterized strains PAO1 and PA14. While these strains were 263 initially isolated from clinical settings, they have subsequently undergone evolution in 264 the laboratory environment (59-61), and might now substantially differ from the 265 clinical strains actually causing acute infections in hospitals. Therefore, while we 266 found no overall differences between the lab strains used in our data set, we argue 267 that it would still be useful to carry out additional studies on a range of clinical 268 isolates to be able to make firm conclusions on the general role of pyoverdine as a 269 virulence factor. Guidelines for future studies. While our study demonstrates the strength of 280 quantitative comparative approaches, it is important to realize that extracting effect 281 sizes is one of the biggest challenges in any meta-analysis. This challenge was 282 particularly evident for the experiments we found, which profoundly varied in the way 283 data was collected and reported. As a consequence, we had to exclude many studies 284 because they used measures of virulence that were only reported by a minority of 285 studies, or because their reporting of results was unclear (for a selected list of 286 examples, see Table S3 in the supplemental material). To amend this issue for future 287 studies, we would like to first highlight the problems we encountered and then 288 provide general guidelines of how data reporting could be improved and 289 standardized. One main problem we experienced was incomplete data reporting (i.e. 290 mean treatment values, absolute values and/or sample size was not reported), which 291 prevents the calculation of effect sizes and uncertainty measures. Another important 292 issue was that different studies measured virulence using very different metrics. 293 Some measured virulence at the tissue level (i.e. the extent of damage inflicted), 294 while others focused on the whole host organism. Others focused on the dynamics of 295 the bacteria themselves, taking this as a proxy for the eventual damage to the host. 296 There were both quantitative measures (e.g. extent of damage), and qualitative 297 measures (e.g. assignments to arbitrary categories of virulence). Survival data was 298 sometimes presented as a timecourse, sometimes as an endpoint; sometimes as raw counts, sometimes as proportions. In most cases, the time scales over which survival 300 was assessed were fairly arbitrary. Compiling such diverse measures of virulence is 301 not simply time consuming, but it also generates extra sources of heterogeneity in 302 the dataset, which might interfere with the basic assumptions of meta-analytical 303 models (62, 63).
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How can these problems be prevented in future studies? We propose the following. replicates must be provided to be able to calculate a confidence estimate for the 310 experiment. (c) If data are scaled in some way (e.g. relative to a reference strain), the 311 absolute values should still be reported, because these are crucial for the calculation 312 of effect sizes. Finally, (d) studies leading to unexpected or negative results (e.g. no 313 difference in virulence between a wildtype and a mutant) should still be published, as 314 they are needed to estimate a true and unbiased effect size. In summary, all findings, 315 irrespective of their magnitude or polarity, should be presented "as raw as possible" 316 (e.g. in supplementary files or deposited in online data archives). This will make 317 comparisons across studies much easier and will provide a useful resource for future 318 meta-analytic studies. 319 320 Conclusions. Currently, bacterial traits are subject to a binary categorisation 321 whereby some are labelled as virulence factors while others are not. We demonstrate 322 that traits' effects on virulence are anything but binary. Rather, they strongly depend 323 on the infection context. Our study affirms meta-analysis as a powerful tool to 324 15 quantitatively estimate the overall effect of a specific virulence factor and to compare 325 its general importance in infections across different bacterial strains, hosts, and host 326 organs. Such quantitative comparisons provide us with a more complete picture on 327 the relative importance of specific virulence factors. Such knowledge is especially 328 valuable for opportunistic pathogens, which have a wide range of virulence factors at 329 their disposal, and infect a broad range of host organisms (13-15). Meta-analytical 330 comparisons could thus inform us on which traits would be best suited as targets for 331 anti-virulence therapies. Ideal traits would be those with high effect sizes and general 332 importance across pathogen and host organisms.
MATERIALS AND METHODS
334
Literature search. We conducted an extensive literature search, using a 335 combination of two online databases: Web of Science and Google Scholar. The 336 following terms were used to search abstracts and full texts: "aeruginosa" in 337 combination with "pyoverdin" or "pyoverdine" and in combination with "virulence" or 338 "infection" or "pathogen" or "disease" or "mortality" or "lethality". This search was first 339 performed on May 19 th 2014 and it was repeated periodically until Sep 21 st 2015 in 340 order to include more recent publications. In addition, the reference lists of all 341 shortlisted studies were scanned for relevant publications. We further contacted the 342 corresponding authors of several publications to ask for unpublished datasets. 343 344 Inclusion criteria. The database search yielded a total of 442 studies, and we 345 identified 10 additional records through other sources. These 452 studies were then 346 scanned for relevant content according to the following set of inclusion criteria. 347 Studies were considered potentially eligible for inclusion if they contained original 348 research, were written in English and provided data that compared the virulence of a 349 wildtype pyoverdine-producing P. aeruginosa strain with that of a mutant strain 350 demonstrating impaired pyoverdine production. We defined virulence as a decrease 351 in host fitness, measured as an increase in mortality or tissue damage when infected 352 with bacteria. We defined "wildtype strains" as strains that were originally clinical 353 isolates, have been widely used in laboratories as virulent reference strains and have 354 not been genetically modified. Strains with impaired pyoverdine production included 355 strains that were completely deficient in pyoverdine production and strains that were 356 only partially deficient, i.e. that produced less than the wildtype strain under identical 357 experimental conditions. We considered both genetically engineered knock-out 358 strains and clinical isolates with reduced pyoverdine production. There were 31 359 original publications containing 115 experiments that satisfied these criteria and were 360 thus considered appropriate for in-depth examination. 361 362 We screened these 115 experiments using a second set of rules to identify those 363 experiments that contain comparable quantitative data, which is essential for a meta- Table S1 in the supplemental material). This information was used to 385 categorize the experiments and identify potentially important moderator variables 386 (see below). 387 388 Next, we extracted quantitative data from these experiments so we could calculate 389 effect sizes for the virulence associated with pyoverdine production. For mortality 390 assays, we extracted raw counts of how many individuals died and how many 391 survived following infection with a dose of P. aeruginosa wildtype or, alternatively, a 392 mutant strain known to be deficient for pyoverdine production. For experiments on 393 tissue damage, we extracted information on the number of individuals with and 394 without the symptoms related to tissue damage (e.g. a lesion in an organ). In cases 395 with zero counts (i.e. either all or none of the individuals in a particular treatment 396 group died or experienced tissue damage), we converted counts to 0.5 to avoid 397 having zero denominators in the subsequent calculations of the (log-odds ratio) effect 398 sizes (66). In cases where data from multiple time-points or survival curves were 399 available, we concentrated on the time point with the largest difference between the 400 wildtype and the mutant infection. For some experiments conducted in mammals, data on in vivo growth of a wildtype 417 and a pyoverdine deficient strain were available in addition to virulence measures (see 418   Table S4 ). We also calculated effect sizes (standardized mean differences) for this set 419 of studies (Fig. S4 ). This limited dataset shows a similar pattern to the main dataset 420 shown in Fig. 1, but Experiments that did not fit in any of these categories, such as infections of whole 437 seedlings, were classified as 'other infection types'. 438 Wildtype strain background -Four different P. aeruginosa wildtypes (PAO1, PA14, 439 FRD1 and PAO6049) were used for infection experiments. Although it is well 440 established that even standard strains such as PAO1 can substantially differ between 441 labs, there was not enough information available to take such strain-level variation into 442 account. 443 Likelihood of pleiotropy -The focal phenotype investigated in this meta-analysis is the 444 production of pyoverdine, the main siderophore of P. aeruginosa. Mutants exhibiting 445 reduced or no pyoverdine production can be generated either by deleting a specific 446 pyoverdine-synthesis gene, or through untargeted mutagenesis (e.g. UV light)(67). 447 The latter mutants are likely to have mutations in other genes unrelated to pyoverdine 448 synthesis. These mutations are typically unknown but could also affect virulence. In 449 principle, even single gene deletions can have pleiotropic effects on the phenotype, 450 via disruption of interactions with other genes. Depending on the locus in question, 451 certain genetic modifications are more likely to induce pleiotropy than others. To 452 account for these complications, we inferred on a case-by-case basis whether the 453 mutation used was likely to only induce a change in (or loss of) pyoverdine production 454 (i.e. pleiotropy less likely) or was likely to induce a change in other phenotypes as well 455 (i.e. pleiotropy more likely). In the biosynthesis of pyoverdine, multiple enzymes are 456 involved in non-ribosomal peptide synthesis (19) . Two gene clusters, the pvc operon 457 and the pvd locus, encode proteins involved in the synthesis of the chromophore and 458 peptide moieties, respectively (19, 68) . In most of these genes, a mutation or deletion 459 leads to a complete loss of pyoverdine production, and most likely does not affect any 460 other trait. Accordingly, we assigned mutants carrying mutations in these genes to the 461 category "pleiotropy less likely". An exception is pvdQ, a gene coding for a periplasmic 462 hydrolase, which is required for pyoverdine production, but is also involved in the Statistical analysis. Analyses were performed in R version 3.2.3 (71), using 484 functions from packages 'meta' (72) and 'metafor' (73). We used the 'metabin' 485 function to transform the count data into the (log-) odds ratio described above. We 486 then weighted these values by the inverse of their respective squared standard 487 errors, and pooled them to obtain a single distribution of effect sizes. We reasoned 488 that the variability of the effect sizes in our dataset probably reflects more than simple 489 sampling error around a single true mean. Rather, we assume that our effect sizes 490 represent a random sample from a larger distribution comprising all possible true 491 effect size estimates. As such, we inferred that a random effects meta-analysis would 492 be more appropriate for our dataset than a fixed effects model (for further discussion, 493 see (62, 63) . In a random effects meta-analysis, we partition the total heterogeneity 494 observed in our dataset (described by the statistic Q) into two constituent parts -495 within-experiment variation (ε) and between-experiment variation (ζ). The latter 496 component, scaled appropriately to account for the weightings intrinsic to meta-497 analysis, is quantified as the τ 2 statistic. There are several different algorithms one 498 can use to effect this partitioning of variance. We chose a restricted maximum 499 likelihood (REML) approach. The use of a random model, rather than a simpler fixed 500 model, affects the weights accorded to each constituent effect size, which in turn 501 changes our estimates for pooled means and their associated errors. We further 502 slightly broadened confidence intervals and weakened test statistics using Knapp 503 and Hartung's algorithm (74)a widely-used and conservative adjustment designed 504 to account for the inherent uncertainty associated with the partitioning of 505 heterogeneity we perform in the course of fitting a random effects model.
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We assessed the degree of residual heterogeneity in our dataset using statistics I 2 508 and H. I 2 estimates the approximate proportion of total variability across experiments 509 that is attributable to unexplained heterogeneity, as opposed to simple sampling error 510 (chance). H reports 'excess' heterogeneity as a fold difference compared to the 511 baseline amount of variability we would have expected if the sample were 512 homogenous (75). 513 514 Both metrics described above indicated considerable residual heterogeneity in our 515 dataset, so we suspected that, beyond the random-and sampling error, some 516 measurable characteristics of the experiments in our dataset could be contributing, in 517 predictable ways, to the observed heterogeneity of our assembled effect sizes. We 518 investigated four potential moderators, namely the host taxon, the type of infection, 519 the wildtype background of the infecting strains, and the type of mutant involved (i.e. 520 whether more or less pleiotropy was expected). In a first approach, we split the 521 dataset into subgroups representing different levels of these moderators, and 522 estimated pooled means within these different subgroups. For this, we again used 523 random-effect meta-analysis (as above), but we set the level of between-experiment 524 heterogeneity (τ 2 ) to be common across all subgroups. 525 526 In a second approach, we fitted a series of meta-regression models that extended 527 our basic model to additionally consider the contributions of multiple moderator 528 factors. Our models were able to estimate moderators' additive effects only, because 529 the distribution of data across different combinations of factor levels was too patchy 530 to permit a proper investigation of moderators' interactive effects. Moderators' 531 alterations of the expected (i.e. baseline) effect size could be quantified as coefficients, which could, when standardized as t-statistics, be tested for significant 533 differences from zero. In addition, we could test whether, collectively, the inclusion of 534 moderators in our meta-analysis model significantly reduced the residual 535 heterogeneity relative to a situation with no moderators. To test for putative publication bias in our dataset, we compared effect sizes against 548 their respective standard errors, the idea being that if there is no bias, there should 549 be no link between the magnitude of the result from a given experiment, and the 550 'noisiness' or uncertainty of that particular result. If there is bias, we could find an 551 overrepresentation of noisier experiments reporting higher magnitude results. Using 552 the 'metabias' function of the R package 'meta', we performed both (weighted) linear 553 regressions and rank correlations to test for this pattern (76, 77 Table S1 in the supplemental material). The numbers in brackets on the Y-axis correspond to the citation number of the corresponding publication.
FIG. 2 Test for differences between subgroups of moderator variables with regard to the effect sizes for pyoverdine as a virulence factor in P. aeruginosa.
Our baseline condition for all comparisons is the following: gut infections in invertebrate hosts, using the P. aeruginosa wildtype strain PA14 vs a pyoverdinedeficient PA14 mutant with a low expected level of pleiotropy. The effect size for this baseline scenario is set to zero. All other scenarios had more extreme (negative) effect sizes, and are therefore scaled relative to this baseline condition. Comparisons reveal that virulence in pyoverdine-deficient strains was significantly more reduced in systemic compared to gut infections, and that most effect size variation is explained by the infection type. There were no significant effect size differences between any of the other subgroups. Bars show the difference in log odds-ratio (± 95% confidence interval) between the baseline and any of the alternate conditions. Values given in brackets indicate percentage of effect size heterogeneity explained by a specific moderator.
FIG. 3 Association between effect sizes and their standard errors across 76
experiments examining the role of pyoverdine production for virulence in P. aeruginosa. In the absence of bias, we should see an inverted funnel-shaped cloud of points, more or less symmetrically distributed around the mean effect size (vertical dotted line). Instead, we see an over-representation of low-certainty experiments associated with strong (negative) effect sizes. This suggests a significant publication bias: experiments with low-certainty and weak or contrary effects presumably do exist, but are under-represented here (note the absence of data points in the cross-hatched triangle). Effect sizes are given as log-odds-ratio. Each symbol represents a single experiment. Symbol colours and shapes stand for different host organisms (red circles = invertebrates; blue squares = mammals; green diamonds = plants). Large symbols denote the experiments included in the core dataset. The solid shaded area represents the 95% confidence interval for the weighted linear regression using the complete dataset. Note that due to the stronger weights accorded to high certainty experiments (i.e. the points towards the top of the plot), many of the lower-weighted (higher-uncertainty) points towards the bottom of the plot lie quite far from the regression line and also outside the confidence interval. We searched (see details in main text) for any reports of experiments featuring monoclonal infections of whole live host organisms with P. aeruginosa strains known to vary in pyoverdine phenotype, where virulence was quantified in terms of host mortality.
Extract and standardize effect sizes and their standard errors
For each case reporting host survival, we calculated the (log) ratio of mortality odds from pyoverdine-mutant infections vs. wildtype infections -i.e. the (log) odds-ratio.
4a. Check heterogeneity across studies
Our assembled effect sizes were more heterogeneous than expected from chance -even when we allowed that some of this variation could be due to random noise.
4b. Consider putative moderator variables (optional)
We tested for evidence of distinct sub-groups in our dataset, within which the effect sizes might be more homogeneous. We identified four putative moderators and codified each study for the following: (i) host taxon; (ii) infection type; (iii) strain background; and (iv) level of pleiotropy expected, given the particular mutation(s) involved.
4c. Check for publication bias (optional)
We found that smaller / lower-powered studies were more likely to report large effect sizes in support of the hypothesis, whereas larger / higher-powered studies tended to report smaller effect sizes.
Derive mean effect size(s); quantify influence of moderator variables (if applicable)
Despite the steps taken (see above), our dataset still showed substantial heterogeneity. Estimates of mean effect sizes (in / across subgroups) and moderator coefficients should therefore be viewed as best approximations.
FIG. S1 Flow diagram (PRISMA format) of the screening and selection process
for studies investigating the association between pyoverdine production and virulence in P. aeruginosa.
FIG. S2 Forest plot depicting the variation in effect size across experiments on
the effect of pyoverdine on the growth of P. aeruginosa in mammalian hosts.
Effect sizes are given as standardized mean difference ± 95% confidence interval and are grouped by host genus. Negative and positive effect sizes indicate lower and higher in vivo growth of the pyoverdine-deficient mutant relative to the wildtype, respectively. IDs of the individual experiments are listed on the Y-axis (for details, see Table S4 in the supplemental material).
